News & Updates

Show Multimedia Only

Polypill cuts risk of cardiovascular disease but not mortality

28 May 2022

Use of a fixed-dose combination therapy or a polypill effectively lowers cardiovascular risk factors but falls short of producing significant reductions in mortality, according to a systematic review and meta-analysis.

Polypill cuts risk of cardiovascular disease but not mortality

28 May 2022

Rapid macular thinning an early sign of hydroxychloroquine retinopathy

28 May 2022

In patients on long-term hydroxychloroquine (HCQ) therapy, rapid macular thinning appears to alert a potential retinal damage related to HCQ treatment, a study has found.

Rapid macular thinning an early sign of hydroxychloroquine retinopathy

28 May 2022

Polypharmacy, wrong prescriptions persist in older cancer patients on immunotherapy

28 May 2022

Inappropriate prescription practices and polypharmacy remain a burden in patients treated with immune checkpoint inhibitors (ICIs), a study has found.

Polypharmacy, wrong prescriptions persist in older cancer patients on immunotherapy

28 May 2022

Medications to lower urate levels effective in CKD patients

28 May 2022

All urate-lowering therapies work to reduce uric acid concentrations in patients with chronic kidney disease (CKD), although it is unclear whether this benefit extends to those with renal disease, according to the results of a meta-analysis.

Medications to lower urate levels effective in CKD patients

28 May 2022

Lebrikizumab reduces asthma exacerbation in adolescents

28 May 2022 by

Treatment with either high- or low-dose lebrikizumab reduces the rate of exacerbation in patients with uncontrolled asthma, according to the ACOUSTICS* trial presented at ATS 2022.

Lebrikizumab reduces asthma exacerbation in adolescents

28 May 2022

Pharmaceutical staff exposed to antineoplastic drug contamination risk

27 May 2022

Pharmaceutical workers who serve in healthcare settings are in danger of antineoplastic drug contamination not just inside the compounding room but also in adjacent rooms, reveals a study.

Pharmaceutical staff exposed to antineoplastic drug contamination risk

27 May 2022

COVID-19 jabs help reduce long-term symptoms

27 May 2022 by

COVID-19 vaccination appears to reduce the odds of long COVID symptoms, with continuous improvement following a second dose, at least in the first few months after the shot, suggests a study.

COVID-19 jabs help reduce long-term symptoms

27 May 2022

Early treatment of ATTR-CM with tafamidis increases survival

27 May 2022 by

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive and life-threatening rare disease caused by unstable transthyretin proteins that misfold and aggregate into insoluble amyloid fibrils that deposit in the heart and other organs of the body. Tafamidis, a transthyretin stabilizer, is the first disease-modifying therapy approved for ATTR-CM. Clinical Assistant Professor Khoo Chun Yuan, Consultant Cardiologist at the National Heart Centre Singapore, discusses the importance of early diagnosis and treatment of ATTR-CM patients.

Early treatment of ATTR-CM with tafamidis increases survival

27 May 2022

Linzagolix benefits Hb levels, mood, QoL

26 May 2022 by

The use of the oral GnRH antagonist linzagolix in patients with heavy menstrual bleeding (HMB) due to uterine fibroids induced multiple benefits including improved haemoglobin (Hb) levels, health-related quality of life (HRQoL), and mood, analysis of the PRIMROSE 1 and 2 trials showed.

Linzagolix benefits Hb levels, mood, QoL

26 May 2022

Meta-analysis proves value of fostemsavir in multidrug-resistant HIV-1

26 May 2022 by

The first-in-class attachment inhibitor fostemsavir, when combined with optimized background therapy (OBT), provides an important treatment option for heavily treated HIV-1 patients with multidrug resistance and limited available antiretroviral (ARV) options, a matching adjusted indirect comparison (MAIC) analysis has shown.

Meta-analysis proves value of fostemsavir in multidrug-resistant HIV-1

26 May 2022

News & Updates

Showing Pharmacy articles

Showing

Specialty:

Polypill cuts risk of cardiovascular disease but not mortality

Polypill cuts risk of cardiovascular disease but not mortality

Rapid macular thinning an early sign of hydroxychloroquine retinopathy

Rapid macular thinning an early sign of hydroxychloroquine retinopathy

Polypharmacy, wrong prescriptions persist in older cancer patients on immunotherapy

Polypharmacy, wrong prescriptions persist in older cancer patients on immunotherapy

Medications to lower urate levels effective in CKD patients

Medications to lower urate levels effective in CKD patients

Lebrikizumab reduces asthma exacerbation in adolescents

Lebrikizumab reduces asthma exacerbation in adolescents

Pharmaceutical staff exposed to antineoplastic drug contamination risk

Pharmaceutical staff exposed to antineoplastic drug contamination risk

COVID-19 jabs help reduce long-term symptoms

COVID-19 jabs help reduce long-term symptoms

Early treatment of ATTR-CM with tafamidis increases survival

Early treatment of ATTR-CM with tafamidis increases survival

Linzagolix benefits Hb levels, mood, QoL

Linzagolix benefits Hb levels, mood, QoL

Meta-analysis proves value of fostemsavir in multidrug-resistant HIV-1

Meta-analysis proves value of fostemsavir in multidrug-resistant HIV-1